![]() ![]() FreeBSD comes with over 20,000 packages (pre-compiled software that is bundled for easy installation), covering a wide range of areas: from server software, databases and web servers, to desktop software, games, web browsers and business software - all free and easy to install. FreeBSD is used by companies, Internet Service Providers, researchers, computer professionals, students and home users all over the world in their work, education and recreation. ![]() JBIDWATCHER 2.99 PRE CODEBerkeley's "Net/2" to the i386, known as "386BSD", though very little of the 386BSD code remains. ![]() It is also based indirectly on William Jolitz's port of U.C. Berkeley's "4.4BSD-Lite" release, with some "4.4BSD-Lite2" enhancements. Category: Desktop, Firewall, Raspberry Pi, ServerįreeBSD is a UNIX-like operating system for the i386, amd64, IA-64, arm, MIPS, powerpc, ppc64, PC-98 and UltraSPARC platforms based on U.C.Desktop: AfterStep, Awesome, Blackbox, Enlightenment, Fluxbox, GNOME, IceWM, KDE Plasma, LXDE, Openbox, WMaker, Xfce.Architecture: arm, aarch64, armel, i386, ia64, mips, mipsel, sparc64, pc98, powerpc, powerpc64, ps3, x86_64, xbox.Sipuleucel-T immunotherapy for castration-resistant prostate cancer. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. doi: 10.3322/caac.21387.Įscudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, et al. Meta-analysis PNI Prognostic nutritional index Urinary cancer. The outcomes of us shed light on that elevated pre-treatment PNI was positively associated with OS, CSS/DSS and DFS/RFS/PFS, indicating that it could be an independent prognostic factor in urinary cancers. As for the treatment subgroup, a relatively lower level of PNI could also be a positive predictor for OS (surgery: HR = 1.64, 95% CI 1.40-1.93 target therapy: HR = 1.88, 95% CI 1.34-2.63) and DFS/RFS/PFS (surgery: HR = 1.69, 95% CI 1.47-1.95 target therapy: HR = 2.14, 95% CI 1.50-3.05). Subsequent stratified analysis by cancer type for OS showed that PNI could also be a predictor no matter in renal cell cancer (RCC) or bladder cancer (BC) (pooled HR = 1.65, 95% CI 1.37-1.97 and pooled HR = 1.67, 95% CI 1.20-2.33). ![]() Our results indicated that a relatively lower level of pre-treatment PNI was associated with decreased OS, CSS/DSS and DFS/RFS/PFS (pooled HR = 1.68, 95% CI 1.45-1.95 pooled HR = 1.57, 95% CI 1.33-1.86 pooled HR = 1.75, 95% CI 1.53-1.99, respectively). The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were extracted to evaluate their associations.Ī total of 12 related articles including 6561 patients were ultimately enrolled. Relevant articles were searched comprehensively from PubMed, Embase and Web of Science, up to November 2018. To investigate the potential prognostic role of pre-treatment prognostic nutritional index (PNI) in urinary cancers. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |